Risk of Acute Kidney Injury After Primary and Revision Total Hip Arthroplasty and Total Knee Arthroplasty Using a Multimodal Approach to Perioperative Pain Control Including Ketorolac and Celecoxib

详细信息    查看全文

• 作者：Lucian C. Warth ; MD^a ; Nicolas O. Noiseux ; MD^b ; Matthew H. Hogue ; MD^b ; Alison L. Klaassen ; MA^b ; Steve S. Liu ; MD^b ; John J. Callaghan ; MD^b ;
• 关键词：acute kidney injury ; total hip arthroplasty ; total knee arthroplasty ; pain control ; nonsteroidal anti-inflammatories
• 刊名：The Journal of Arthroplasty
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：31
• 期：1
• 页码：253-255
• 全文大小：176 K

文摘

Safe and effective perioperative analgesia is instrumental to patient satisfaction and decreasing LOS after TJA. We evaluated rates of acute kidney injury (AKI) in primary and revision TJA using a multimodal pain control regimen including scheduled celecoxib and PRN ketorolac. Postoperative AKI was identified in 43/903 (4.8%) of 903 of patients with adequate preoperative renal function. Those who developed AKI had significantly increased LOS (P < .01), were older, more obese, and more likely to have diabetes (P < .05). With a protocol incorporating NSAIDs in patients without evidence of preoperative renal impairment, there is a 4.8% rate of AKI, which is 2.7 times higher than the reported literature. Acute postoperative kidney injury was significantly correlated with increased LOS and has important patient safety and healthcare–related cost implications.